Cardiovascular Risk Assessment Using Artificial Intelligence-Enabled Event Adjudication and Hematologic Predictors

Researchers routinely evaluate novel biomarkers for incorporation into clinical risk models, weighing tradeoffs between cost, availability, and ease of deployment. For risk assessment in population health initiatives, ideal inputs would be those already available for most patients. We hypothesized t...

Descripción completa

Detalles Bibliográficos
Autores principales: Truslow, James G., Goto, Shinichi, Homilius, Max, Mow, Christopher, Higgins, John M., MacRae, Calum A., Deo, Rahul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208816/
https://www.ncbi.nlm.nih.gov/pubmed/35477255
http://dx.doi.org/10.1161/CIRCOUTCOMES.121.008007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208816/
https://www.ncbi.nlm.nih.gov/pubmed/35477255
http://dx.doi.org/10.1161/CIRCOUTCOMES.121.008007

Ejemplares similares